Learn About

VENTUREMED GROUP

Learn About

VENTUREMED GROUP

Our Story

VentureMed develops and markets innovative endovascular devices that address unmet needs in the treatment of peripheral arterial disease (PAD) and stenoses of AV fistulas & grafts.

In 2012, practicing vascular surgeon, John P. Pigott, MD, FACS realized there was an unmet need in vessel preparation for the treatment of peripheral artery disease (PAD). With support from Promedica Innovations, Dr. Pigott founded the VentureMed Group to design, develop, and market cost-effective interventional devices to improve patient outcomes and reduce the overall cost of care for the provider and the procedure.

The FLEX Vessel Prep™ System was designed by Dr. Pigott to safely and  predictably modify plaque by creating controlled, micro-incisions of any length in complex  lesions of varying morphology, providing acute luminal gain & improved vessel compliance, and enabling consistent, superior clinical revascularization outcomes in PAD.

Our Story

VentureMed develops and markets innovative endovascular devices that address unmet needs in the treatment of peripheral arterial disease (PAD) and stenoses of AV fistulas & grafts.

In 2012, practicing vascular surgeon, John P. Pigott, MD, FACS realized there was an unmet need in vessel preparation for the treatment of peripheral artery disease (PAD). With support from Promedica Innovations, Dr. Pigott founded the VentureMed Group to design, develop, and market cost-effective interventional devices to improve patient outcomes and reduce the overall cost of care for the provider and the procedure.

The FLEX Vessel Prep™ System was designed by Dr. Pigott to safely and  predictably modify plaque by creating controlled, micro-incisions of any length in complex  lesions of varying morphology, providing acute luminal gain & improved vessel compliance, and enabling consistent, superior clinical revascularization outcomes in PAD.

Company

Company

VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.

VentureMed Group, Inc. develops and markets innovative endovascular medical devices to solve unmet medical needs in the treatment of PAD and stenoses of AV fistulas and grafts.